UK clinical guideline for the prevention and treatment of osteoporosis

J Compston, A Cooper, C Cooper, N Gittoes, C Gregson, N Harvey, S Hope, J A Kanis, E V McCloskey, K E S Poole, D M Reid, P Selby, F Thompson, A Thurston, N Vine, National Osteoporosis Guideline Group (NOGG)

Research output: Contribution to journalArticle

145 Citations (Scopus)
9 Downloads (Pure)

Abstract

INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.

METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.

RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.

CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

Original languageEnglish
Article number43
Pages (from-to)1-24
Number of pages24
JournalArchives of Osteoporosis
Volume12
Early online date19 Apr 2017
DOIs
Publication statusPublished - Dec 2017

Fingerprint

Osteoporosis
Guidelines
Therapeutics
Delivery of Health Care
Accreditation
National Institutes of Health (U.S.)
Diphosphonates
Glucocorticoids
Meta-Analysis
Life Style
Randomized Controlled Trials
Pharmacology

Keywords

  • Osteoporosis
  • fracture
  • NOGG
  • guideline

Cite this

Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., ... National Osteoporosis Guideline Group (NOGG) (2017). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 12, 1-24. [43]. https://doi.org/10.1007/s11657-017-0324-5

UK clinical guideline for the prevention and treatment of osteoporosis. / Compston, J; Cooper, A; Cooper, C; Gittoes, N; Gregson, C; Harvey, N; Hope, S; Kanis, J A; McCloskey, E V; Poole, K E S; Reid, D M; Selby, P; Thompson, F; Thurston, A; Vine, N; National Osteoporosis Guideline Group (NOGG).

In: Archives of Osteoporosis, Vol. 12, 43, 12.2017, p. 1-24.

Research output: Contribution to journalArticle

Compston, J, Cooper, A, Cooper, C, Gittoes, N, Gregson, C, Harvey, N, Hope, S, Kanis, JA, McCloskey, EV, Poole, KES, Reid, DM, Selby, P, Thompson, F, Thurston, A, Vine, N & National Osteoporosis Guideline Group (NOGG) 2017, 'UK clinical guideline for the prevention and treatment of osteoporosis', Archives of Osteoporosis, vol. 12, 43, pp. 1-24. https://doi.org/10.1007/s11657-017-0324-5
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al. UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis. 2017 Dec;12:1-24. 43. https://doi.org/10.1007/s11657-017-0324-5
Compston, J ; Cooper, A ; Cooper, C ; Gittoes, N ; Gregson, C ; Harvey, N ; Hope, S ; Kanis, J A ; McCloskey, E V ; Poole, K E S ; Reid, D M ; Selby, P ; Thompson, F ; Thurston, A ; Vine, N ; National Osteoporosis Guideline Group (NOGG). / UK clinical guideline for the prevention and treatment of osteoporosis. In: Archives of Osteoporosis. 2017 ; Vol. 12. pp. 1-24.
@article{e064795a01254085bec87dc0e0e3dbaa,
title = "UK clinical guideline for the prevention and treatment of osteoporosis",
abstract = "INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.",
keywords = "Osteoporosis, fracture , NOGG , guideline",
author = "J Compston and A Cooper and C Cooper and N Gittoes and C Gregson and N Harvey and S Hope and Kanis, {J A} and McCloskey, {E V} and Poole, {K E S} and Reid, {D M} and P Selby and F Thompson and A Thurston and N Vine and {National Osteoporosis Guideline Group (NOGG)}",
year = "2017",
month = "12",
doi = "10.1007/s11657-017-0324-5",
language = "English",
volume = "12",
pages = "1--24",
journal = "Archives of Osteoporosis",
issn = "1862-3522",
publisher = "Springer",

}

TY - JOUR

T1 - UK clinical guideline for the prevention and treatment of osteoporosis

AU - Compston, J

AU - Cooper, A

AU - Cooper, C

AU - Gittoes, N

AU - Gregson, C

AU - Harvey, N

AU - Hope, S

AU - Kanis, J A

AU - McCloskey, E V

AU - Poole, K E S

AU - Reid, D M

AU - Selby, P

AU - Thompson, F

AU - Thurston, A

AU - Vine, N

AU - National Osteoporosis Guideline Group (NOGG)

PY - 2017/12

Y1 - 2017/12

N2 - INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

AB - INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

KW - Osteoporosis

KW - fracture

KW - NOGG

KW - guideline

U2 - 10.1007/s11657-017-0324-5

DO - 10.1007/s11657-017-0324-5

M3 - Article

C2 - 28425085

VL - 12

SP - 1

EP - 24

JO - Archives of Osteoporosis

JF - Archives of Osteoporosis

SN - 1862-3522

M1 - 43

ER -